Cabot Corporation (NYSE:CBT)‘s stock had its “hold” rating reiterated by investment analysts at KeyCorp in a note issued to investors on Wednesday, November 1st.
CBT has been the subject of several other reports. Loop Capital started coverage on Cabot Corporation in a research report on Thursday, September 28th. They set a “hold” rating and a $59.00 target price for the company. Zacks Investment Research downgraded Cabot Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. ValuEngine downgraded Cabot Corporation from a “buy” rating to a “hold” rating in a research report on Friday, July 28th. J P Morgan Chase & Co raised Cabot Corporation from a “neutral” rating to an “overweight” rating and set a $57.00 price objective on the stock in a report on Tuesday, August 15th. Finally, BidaskClub cut Cabot Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Six analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Cabot Corporation has a consensus rating of “Hold” and a consensus price target of $61.14.
Cabot Corporation (NYSE:CBT) traded up $0.03 during trading on Wednesday, hitting $62.24. The company’s stock had a trading volume of 295,600 shares, compared to its average volume of 354,438. The company has a market cap of $3,851.66, a PE ratio of 18.15, a price-to-earnings-growth ratio of 1.64 and a beta of 1.11. Cabot Corporation has a 52-week low of $49.70 and a 52-week high of $64.66. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.70 and a quick ratio of 1.17.
Cabot Corporation (NYSE:CBT) last issued its earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.93 by ($0.02). Cabot Corporation had a return on equity of 15.11% and a net margin of 8.87%. The firm had revenue of $723.00 million during the quarter, compared to the consensus estimate of $683.30 million. During the same quarter in the prior year, the business earned $1.00 earnings per share. Cabot Corporation’s revenue for the quarter was up 16.8% on a year-over-year basis. sell-side analysts expect that Cabot Corporation will post 3.79 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Cabot Corporation (NYSE:CBT) Rating Reiterated by KeyCorp” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2017/11/12/keycorp-reiterates-hold-rating-for-cabot-corporation-cbt.html.
In other news, insider Hobart Kalkstein sold 3,881 shares of the business’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $53.39, for a total value of $207,206.59. Following the completion of the transaction, the insider now owns 27,736 shares in the company, valued at $1,480,825.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.50% of the stock is owned by insiders.
Institutional investors have recently bought and sold shares of the stock. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Cabot Corporation by 9.2% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,469 shares of the specialty chemicals company’s stock valued at $132,000 after acquiring an additional 209 shares during the last quarter. Old Mutual Global Investors UK Ltd. purchased a new stake in Cabot Corporation during the second quarter valued at $155,000. Integrated Investment Consultants LLC increased its position in Cabot Corporation by 66.1% during the second quarter. Integrated Investment Consultants LLC now owns 3,097 shares of the specialty chemicals company’s stock valued at $165,000 after acquiring an additional 1,233 shares during the last quarter. Parametrica Management Ltd purchased a new stake in Cabot Corporation during the third quarter valued at $217,000. Finally, Virginia Retirement Systems ET AL purchased a new stake in Cabot Corporation during the third quarter valued at $218,000. Institutional investors own 84.66% of the company’s stock.
About Cabot Corporation
Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.
Receive News & Ratings for Cabot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Corporation and related companies with MarketBeat.com's FREE daily email newsletter.